pentobarbital decreases effects of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Carefully. Coadministration of CYP3A4 inducers could decrease sufentanil amounts and efficacy, probably precipitating withdrawal syndrome in people who may have developed B